Journal of Diagnostics Concepts & Practice >
Detection rate of gastric polyps and its clinical characteristics in 36 857 subjects in Shanghai
Received date: 2019-07-01
Online published: 2022-07-15
Objective: To explore the detection rate of gastric polyp (GP) in Shanghai and analyze its clinical characteristics. Methods: A total of 36 857 subjects undergone gastroscopy during December 2012 to May 2019 were enrolled, and the detection rate of GP and related pathologic data were analyzed. Results: It revealed that 3 858 patients had GP, with a detection rate of 10.47%. In patients over 60 years old, 1 534 patients were diagnosed as having GP, with a detection rate of 14.75%. Compared with patients in other age groups (<30, 30-39, 40-49, 50-59 years), the constituent ratio of patients with GP diameter ≥2.0 was higher(1.8%)(P<0.05), so was with adenomatous polyps (1.9%) and with intraepithelial neoplasia (2.9%)(P<0.05). The only three cases with high-grade intraepithelial neoplasia were all ≥60 years old. Besides, the constituent ratio of patients ≥60 years old with atrophic gastritis and with intestinal metaplasia were 22.4% and 34.0%, respectively,which were higher than those of patients <60 years old. In contrast, GP patients ≥60 years old had a lower constituent ratio of Helicobacter pylori infection (15.1%), lower than that of patients under 60 years old (P<0.01). Conclusions: In comparison with the population <60 years old, population ≥60 had a higher detection rate of GP. GP patients of ≥60 years old had higher proportion of polyps diameter greater than 2 cm, adenomatous polyps, intraepithelial neoplasia, atrophic gastritis, and intestinal metaplasia. Therefore, more attention should be paid to the detection and pathology examination of GP in elderly patients.
ZHOU Yufen, WONG Bokai, LUO Fangxiu, XU Ying, DING Yanfei, YUAN Xiaoqin, CHEN Ping, WU Yunlin . Detection rate of gastric polyps and its clinical characteristics in 36 857 subjects in Shanghai[J]. Journal of Diagnostics Concepts & Practice, 2020 , 19(04) : 420 -425 . DOI: 10.16150/j.1671-2870.2020.04.018
[1] | 陈灏珠, 林果为. 实用内科学[M]. 北京: 人民卫生出版社, 2013. |
[2] | Sonnenberg A, Genta RM. Prevalence of benign gastric polyps in a large pathology database[J]. Dig Liver Dis, 2015, 47(2):164-169. |
[3] | Fan NN, Yang J, Sun G, et al. Changes in the spectrum of gastric polyps in the Chinese population[J]. World J Gastroenterol, 2015, 21(33):9758-9764. |
[4] | Kelly PJ, Lauwers GY. Clinical guidelines: consensus for the management of patients with gastric polyps[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(1):7-8. |
[5] | Cao H, Wang B, Zhang Z, et al. Distribution trends of gastric polyps: an endoscopy database analysis of 24 121 northern Chinese patients[J]. J Gastroenterol Hepatol, 2012, 27(7):1175-1180. |
[6] | Wang HB, Xu L. Clinical features analysis in 365 cases of gastric polyps[J]. Clinical Medicine of China, 2010, 26:581-584. |
[7] | Wei X. Clinical and pathological analysis in 579 cases of gastric polyps[J]. Chinese Journal of Laboratory Diagnosis. 2009, 13:951-952. |
[8] | Argüello Viúdez L, Córdova H, Uchima H, et al. Gastric polyps: retrospective analysis of 41,253 upper endoscopies[J]. Gastroenterol Hepatol[J]. Gastroenterol Hepatol, 2017, 40(8):507-514. |
[9] | Martin FC, Chenevix-Trench G, Yeomans ND. Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors[J]. Aliment Pharmacol Ther, 2016, 44(9):915-925. |
[10] | Fukuda M, Ishigaki H, Sugimoto M, et al. Histological analysis of fundic gland polyps secondary to PPI therapy[J]. Histopathology, 2019, 75(4):537-545. |
[11] | Jain R, Chetty R. Gastric hyperplastic polyps: a review[J]. Dig Dis Sci, 2009, 54(9):1839-1846. |
[12] | Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer[J]. World J Gastroenterol, 2014, 20(38):13804-13819. |
[13] | Fan NN, Yang J, Sun G, et al. Changes in the spectrum of gastric polyps in the Chinese population[J]. World J Gastroenterol, 2015, 21(33):9758-9764. |
[14] | Yoon SB, Park JM, Lim CH, et al. Incidence of gastric cancer after endoscopic resection of gastric adenoma[J]. Gastrointest Endosc, 2016, 83(6):1176-1183. |
[15] | Goddard AF, Badreldin R, Pritchard DM, et al. The management of gastric polyps[J]. Gut, 2010, 59(9):1270-1276. |
[16] | Markowski AR, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps[J]. World J Gastroenterol, 2016, 22(40):8883-8891. |
[17] | Carmack SW, Genta RM, Schuler CM, et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients[J]. Am J Gastroenterol, 2009, 104(6):1524-1532. |
[18] | Na HK, Cho CJ, Bae SE, et al. Atrophic and metaplastic progression in the background mucosa of patients with gastric adenoma[J]. PLoS One, 2017, 12(1):e0169456. |
[19] | Fukuda M, Ishigaki H, Ban H, et al. No transformation of a fundic gland polyp with dysplasia into invasive carcinoma after 14 years of follow-up in a proton pump inhibitor-treated patient: A case report[J]. Pathol Int, 2018, 68(12):706-711. |
/
〈 |
|
〉 |